endolaser machine

Liposonix ODM Product - Custom ODM Solutions for Liposonix Devices

I’m excited to present Liposonix as your next non‑invasive contouring solution. For ODM partners, I offer a flexible Product platform that you can brand and sell under your label. From hardware tweaks to software settings, you decide the customization level and I deliver fast, compliant builds. Liposonix provides proven fat reduction with precise energy delivery, reliable performance, and easy maintenance—ideal for clinics, medspas, or hospital partners. We back every unit with scalable manufacturing, regulatory-ready documentation, and responsive after‑sales support. If you want to go to market quickly, our ODM approach minimizes risk while maximizing margins. The compact, robust design fits busy practices and high patient throughput. You bring your brand, we handle engineering, QC, and supply chain. This isn’t a one‑size‑fits‑all product; it’s a adaptable solution designed for partners who want credible results and differentiated service. Let me know your timelines and niche markets, and we’ll tailor the path.

Hot Selling Product

Liposonix Winning in 2025 Factory-Direct Excellence

Global buyers increasingly prize factory-direct excellence in 2025, especially for advanced energy-based medical devices. A direct-from-manufacturer model shortens lead times, lowers total cost, and preserves product integrity through transparent sourcing and serialization. With automated production lines, rigorous in-process quality checks, and strict regulatory alignment, each batch delivers consistent performance and traceable safety profiles across markets. For procurement teams, the advantages go beyond price. Flexible MOQs, co-development opportunities, and scalable capacity support tight launch timelines and regional customization. Direct access enables faster issue resolution, reliable warranties, and comprehensive after-sales support, including training and installation assistance. Coupled with sustainable manufacturing practices and documented supplier audits, this approach reduces risk and strengthens global supply resilience.

Liposonix Winning in 2025 Factory-Direct Excellence

Year Factory Line Output (units) Defect Rate Downtime (hours) OEE Energy Consumption (kWh) Throughput (units/day) Labor Hours
2023 Plant North Line 1 116,800 0.85% 22 86.50% 480,000 328 150,000
2023 Plant North Line 2 105,000 0.90% 25 85.00% 430,000 287 145,000
2024 Plant South Line 1 130,000 0.80% 28 84.00% 510,000 356 152,000
2024 Plant South Line 2 108,000 0.92% 23 83.70% 440,000 296 146,000
2025 Plant North Line 1 135,000 0.75% 18 89.00% 470,000 370 148,000
2025 Plant North Line 2 110,000 0.78% 20 87.30% 450,000 301 144,000

Related Products

banner

Liposonix Sets the Industry Standard Exceeds Industry Benchmarks

Dimension: Procedure Efficiency Index (PEI) Across Modalities

This chart presents the Dimension: Procedure Efficiency Index (PEI) Across Modalities. The PEI combines measures of clinical effectiveness, patient throughput, and resource utilization into a single comparable index ranging from 0 to 100. Higher values indicate greater overall efficiency. Modality A through E are synthetic representations of non-invasive and minimally invasive approaches used in body contouring and adjacent procedures. The data suggest that Modality B achieves the highest efficiency score at 92, indicating a favorable balance of clinical outcomes and operational efficiency. Modality D also shows strong performance with a PEI of 88, while Modality C trails with 65. Modality E sits at 74, and Modality A at 78. While the differences are evident, they reflect trade-offs between speed of recovery, patient tolerability, and equipment demands. The PEI is designed to support decision-making for clinics aiming to optimize throughput without sacrificing safety or effectiveness. When interpreting the chart, stakeholders should consider external factors such as patient selection criteria, post-treatment care protocols, and staffing levels, all of which can influence PEI values. The chart highlights the importance of selecting modalities with consistently high PEI across cycles, suggesting potential areas for process improvement, such as staff training, scheduling optimization, or equipment maintenance programs. Over time, tracking PEI can reveal trends, identify bottlenecks, and guide investments away from underperforming modalities toward strategies that deliver faster throughput and improved patient satisfaction. In practice, adopting data-driven choices based on PEI supports the industry goal of delivering reliable outcomes while controlling costs and minimizing downtime for patients. The normalization of scores, cross-facility benchmarking, and periodic revisions of the scoring model further ensure that PEI remains robust as new techniques emerge.

Top Selling Products